LYPD3 and melanoma: Considering that JUP is a homologue of β-catenin and is closely related to β-catenin in many cases to concertedly regulate cell fate, we speculate that there may be a mechanism of JUP/AGR2/LYPD3 signaling regulation in melanoma.